Per Ladenvall

Publication Activity (10 Years)

Years Active: 2019-2022
Publications (10 Years): 4

Top Topics

Antiplatelet Therapy

Blood Brain Barrier

Acute Ischemic Stroke

Top Venues

Clinical trials (London, England)

Sahlgrenska universitetssjukhuset

Goteborgs Universitet Sahlgrenska Akademin (PHD)

This page only lists publications with an associated author ORCID identifier.

Affiliation History

Sahlgrenska universitetssjukhuset Sep 10 2010

Sweden

Cardiologist :: Dept of Medicine, Section for Cardiology

Education History

Goteborgs Universitet Sahlgrenska Akademin - Mar 01 2002

Sweden

PHD :: Cardiovascular Institute

Publications

Yongjun Wang, Yue-Song Pan, Hao Li, Pierre Amarenco, Hans Denison, Scott R Evans, Anders Himmelmann, Stefan K James, Mikael Knutsson, Per Ladenvall, Carlos A Molina, S Claiborne Johnston
Time Course for Benefit and Risk of Ticagrelor and Aspirin in Acute Ischemic Stroke or Transient Ischemic Attack. Neurology 99 (1) (2022)
S Claiborne Johnston, Pierre Amarenco, Maria Aunes, Hans Denison, Scott R Evans, Anders Himmelmann, Marianne Jahreskog, Stefan K James, Mikael Knutsson, Per Ladenvall, Carlos A Molina, Sven Nylander, Joachim Röther, Yong-Jun Wang, null null
Ischemic Benefit and Hemorrhage Risk of Ticagrelor-Aspirin Versus Aspirin in Patients With Acute Ischemic Stroke or Transient Ischemic Attack. Stroke 52 (11) (2021)
Scott R Evans, Mikael Knutsson, Pierre Amarenco, Gregory W Albers, Philip M Bath, Hans Denison, Per Ladenvall, Jenny Jonasson, J Donald Easton, Kazuo Minematsu, Carlos A Molina, Yongjun Wang, Ks Lawrence Wong, S Claiborne Johnston
Methodologies for pragmatic and efficient assessment of benefits and harms: Application to the SOCRATES trial. Clinical trials (London, England) 17 (6) (2020)
Brett Cucchiara, Donna Kurowski George, Scott E Kasner, Mikael Knutsson, Hans Denison, Per Ladenvall, Pierre Amarenco, S Claiborne Johnston
Disability after minor stroke and TIA: A secondary analysis of the SOCRATES trial. Neurology 93 (7) (2019)